Clinical trial
Observational Retro-prospective Study on PD1/PDL1 Inhibitors Treatment Duration in Patients With NSCLC
NCT05418660
Study timeline
Study start (actual)2022-05-19Date precision: day
Registry last updated2023-09-18
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non-small Cell Lung Cancerunresolved
Interventions
ImmunotherapyDRUG
Sponsors & collaborators
University of Milano Bicoccalead sponsor
Azienda Ospedaliera San Gerardo di Monzacollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05418660 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.